BackSumitomo Pharma , Ltd. Overview

Sumitomo Pharma , Ltd. Intangible Assets

Latest intangible assets for SMDPY: $150B.

Get informed when a big investor buys or sells

+ Follow
Intangible Assets
$154.04B
↓ 8.94% YoYΔ $-15.13B vs prior year quarter

Peer trimmed avg / median

Loading

Sumitomo Pharma , Ltd. Intangible Assets History

Loading

Sumitomo Pharma , Ltd. vs. peers: Intangible Assets Comparison

Loading

Sumitomo Pharma , Ltd. Intangible Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sumitomo Pharma , Ltd. (SMDPY) FAQ

The latest intangible assets for SMDPY is $150B as of September 2026. That compares with $170B in the prior-year period — down 8.9% year over year. Investors often review this figure alongside Sumitomo Pharma , Ltd.'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SMDPY's intangible assets moved from $170B to $150B — a 8.9% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Sumitomo Pharma , Ltd.'s operating scale or balance-sheet position.

A intangible assets figure of $150B for SMDPY is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting SMDPY's intangible assets ($150B), review year-over-year change from $170B, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.